
|Slideshows|June 14, 2019
Parkinson Disease: 5 Updates
Author(s)Leo Robert
Pain related to more severe motor symptoms, phosphodiesterase 10A loss seen early, novel therapy shows promise, and other recent findings are summarized here.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Investigational COYA 302 Shows Feasibility, Preliminary Efficacy in Small Trial of Frontotemporal Dementia
2
Efficacy and Safety Data for Tavapadon as an Emerging Therapy in Parkinson’s Disease
3
Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival
4
Efgartigimod Application Submitted for Seronegative gMG, EC Approves High-Dose Nusinersen, Copper Histidinate Gains First Approval for Menkes Disease
5



























